Skip to content
value.today

Panacela Labs, Inc.

🇺🇸 Buffalo, New York, USABiotechnologyFounded 2011

Formerly Bio Tar, Inc.

Total raised
$40 M
2 rounds on record
Latest round
$3 M
Dec 2015
First round on record
Oct 2011
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Panacela Labs, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2015$3 MNo. 2$2 to $10 million

Panacela Labs, Inc.: Raise no. 2, Dec 2015

Investors in this round

2 investors had bought by the notice of Dec 23, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Leah Brownlee · Executive Officer, Director
  • Neil Lyons C · Executive Officer, Director
  • Yakov Lyons Kogan · Executive Officer
  • Andrei Lyons Gudkov · Director
  • Dmitry Lyons Lisenkov · Director
  • Leysan Shaydullina · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by C. Neil Lyons, Secretary and Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 23, 2015. Read the notice at the SEC.

equitySEC
Oct 2011$37 MNo. 1$10 to $50 million

Panacela Labs, Inc.: Raise no. 1, Oct 2011

Investors in this round

4 investors had bought by the notice of Oct 7, 2011: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$37 M of $37 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dmitry Tyomkin · Executive Officer, Director
  • Andrei Gudkov · Director
  • Dmitry Lisenkov · Director
  • Michael Fonstein · Director
  • Oleg Kiselev · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dmitry Tyomkin, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 7, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Panacela Labs, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2015).

    SEC Form D · Dec 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2015

That is all the official record says: Panacela Labs, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Panacela Labs, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Panacela Labs, Inc.
NameRoleNamed in
Leah BrownleeExecutive officerDec 2015
Neil Lyons CExecutive officerDec 2015
Yakov Lyons KoganExecutive officerDec 2015
Dmitry TyomkinExecutive officerOct 2011
Andrei Lyons GudkovDirectorDec 2015
Dmitry Lyons LisenkovDirectorDec 2015
Leah BrownleeDirectorDec 2015
Leysan ShaydullinaDirectorDec 2015
Neil Lyons CDirectorDec 2015
Andrei GudkovDirectorOct 2011
Dmitry LisenkovDirectorOct 2011
Dmitry TyomkinDirectorOct 2011
Michael FonsteinDirectorOct 2011
Oleg KiselevDirectorOct 2011